Vaxxas secures $2M grant from BARDA to develop needle-free mRNA vaccines
Vaxxas, a clinical-stage biotechnology company specializing in high-density microarray patch (HD-MAP) vaccine delivery, has been awarded a $2 million (AUD 3.2 million) grant as a Concept Stage winner in the United States Biomedical Advanced Research and Development Authority’s (BARDA) $50 million Patch Forward Prize.
Industry assistance falls to $15B: Productivity Commission’s 50th review
The Productivity Commission has unveiled its 50th annual Trade and Assistance Review (TAR), detailing the amount of industry assistance provided by the Australian Government for the 2022-23 fiscal year.
Moderna announces new head of mRNA vaccine manufacturing site in Melbourne
Global medical technology company Moderna has appointed Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in Australia.
Moderna’s vaccine manufacturing hub in Victoria nears completion ahead of schedule
Victoria is one step closer to locally manufacturing mRNA vaccines and medicines, with the construction of Moderna’s mRNA vaccine manufacturing facility reaching the halfway mark, progressing faster than originally planned.
Queensland’s employment forecasted to grow significantly by 2025-26
The Anticipating Future Skills Series from Jobs Queensland has released four headline employment forecasts for the five-year period 2025-26, estimating total employment of nearly three million, an increase of 207,000 new jobs.
